CD4 T cell-mediated alloresistance to fully MHC-mismatched allogeneic bone marrow engraftment is dependent on CD40-CD40 ligand interactions, and lasting T cell …

H Ito, J Kurtz, J Shaffer, M Sykes - The Journal of Immunology, 2001 - journals.aai.org
Costimulatory blockade can be used to promote allogeneic marrow engraftment and
tolerance induction, but on its own is not 100% reliable. We sought to determine whether …

Design and validation of inducible TurboCARs with tunable induction and combinatorial cytokine signaling

RJ Lin, AR Nager, S Park, J Sutton, C Lay… - Cancer Immunology …, 2022 - AACR
Although cytokine support can enhance CAR T-cell function, coadministering cytokines or
engineering CAR T cells to secrete cytokines can result in toxicities. To mitigate these safety …

Augmentation of naive, Th1 and Th2 effector CD4 responses by IL‐6, IL‐1 and TNF

SB Joseph, KT Miner, M Croft - European journal of …, 1998 - Wiley Online Library
The role of antigen‐presenting cell (APC)‐derived cytokines in T cell activation is still
controversial. Highly purified CD4 T cell populations of the naive and short‐term Th1 and …

[HTML][HTML] Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice

HF Gou, J Huang, HS Shi, X Chen, YS Wang - PloS one, 2014 - journals.plos.org
Combination of immunotherapy and chemotherapy has shown promise for cancer.
Interleukin-7 (IL-7) can potentially enhance immune responses against tumor, while …

Regulation of interleukin‐12 receptor β1 chain expression and interleukin‐12 binding by human peripheral blood mononuclear cells

CY Wu, RR Warrier, X Wang… - European journal of …, 1997 - Wiley Online Library
Abstract The interleukin‐12 receptor (IL‐12R) β1 chain is an essential component of the
functional IL‐12R on both human T and natural killer cells. In this report it is shown that …

[HTML][HTML] T cells expressing constitutively active Akt resist multiple tumor-associated inhibitory mechanisms

J Sun, G Dotti, LE Huye, AE Foster, B Savoldo… - Molecular Therapy, 2010 - cell.com
Adoptive transfer of antigen-specific cytotoxic T lymphocytes has shown promise for the
therapy of cancer. However, tumor-specific T cells are susceptible to diverse inhibitory …

Interleukin-7 Is a Survival Factor for CD4+ CD25+ T-Cells and Is Expressed by Diabetes-Suppressive Dendritic Cells

J Harnaha, J Machen, M Wright, R Lakomy, A Styche… - Diabetes, 2006 - Am Diabetes Assoc
Dendritic cells can facilitate allograft survival and prevent autoimmunity via direct and
indirect cell-mediated mechanisms. Recent studies demonstrate that immunoregulatory …

Human dendritic cells express functional interleukin-7

RV Sorg, AD McLellan, BD Hock, DB Fearnley… - Immunobiology, 1998 - Elsevier
Interleukin-7 (IL-7) supports the proliferation of mature T lymphocytes, however, the cellular
source of IL-7 for T lymphocyte activation has not been well established. We therefore …

IL-7 and lymphopenia

F Ponchel, RJ Cuthbert, V Goëb - Clinica Chimica Acta, 2011 - Elsevier
Interleukin-7 (IL-7) is a growth and anti-apoptotic factor for T-lymphocytes, with potential for
clinical use in the treatment of immunodeficiencies due to loss of T-cells. Lymphopenia …

Regulation of nuclear gamma interferon gene expression by interleukin 12 (IL-12) and IL-2 represents a novel form of posttranscriptional control

DL Hodge, A Martinez, JG Julias… - … and cellular biology, 2002 - Taylor & Francis
Posttranscriptional control of gamma interferon (IFN-γ) gene expression has not been
extensively studied and is poorly understood. Our work describes a posttranscriptional …